Enhanced gastroduodenal motility in children

Area of Science:

• Pediatric Gastroenterology
• Pharmacology

Background:

• Gastric stasis and unexplained vomiting are common pediatric issues.
• Metoclopramide is a prokinetic agent used to treat gastrointestinal motility disorders.

Purpose of the Study:

• To evaluate the efficacy and safety of metoclopramide hydrochloride in pediatric patients with gastric stasis and unexplained vomiting.
• To assess the impact of metoclopramide on gastric and duodenal motility and clinical symptoms.

Main Methods:

• Nine children received metoclopramide for gastric stasis (N=6) or unexplained vomiting (N=3).
• Gastric and duodenal motility, along with eight clinical aspects, were monitored.
• Symptom improvement and freedom from symptoms were assessed over one month.

Main Results:

• Metoclopramide increased the frequency and forcefulness of gastric and duodenal waves in treated patients.
• All monitored clinical aspects showed improvement during therapy, with time-dependent rates.
• After one month, the median symptom improvement rate was 86%, and symptom freedom was 54%.

Conclusions:

• Metoclopramide hydrochloride demonstrated safety and efficacy in treating pediatric gastric stasis and vomiting.
• Sustained clinical improvement was observed even after discontinuing the medication.
• The drug enhanced gastrointestinal motility, leading to significant symptom relief in children.